Pharmaleads CEO to Present at Bio-Europe 2017
Substituted α-mercaptoketones, new types of specific neprilysin inhibitors
Dual enkephalinase inhibitor (DENKI) PL265: a novel topical treatment for ocular pain ?
Pharmaleads Reports Positive Ocular Pain Results with PL265, a Novel Dual Enkephalinase Inhibitor (DENKI), at the ARVO 2017 Annual Meeting
Pharmaleads on Twitter
Board of Directors
Cutting-Edge pain relief
News & events
Contact & find us
No posts yet.
Discover our publications